Debra-Lynn Day-Salvatore, M.D., PH.D
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $5,382 | 1 | 49.5% |
| Consulting Fee | $3,003 | 1 | 27.6% |
| Travel and Lodging | $1,769 | 7 | 16.3% |
| Food and Beverage | $722.05 | 21 | 6.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $6,612 | 15 | $0 (2024) |
| Shire North American Group Inc | $4,187 | 11 | $0 (2017) |
| PFIZER INC. | $31.54 | 2 | $0 (2017) |
| Takeda Pharmaceuticals U.S.A., Inc. | $26.11 | 1 | $0 (2022) |
| Alexion Pharmaceuticals, Inc. | $19.50 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $42.31 | 1 | GENZYME CORPORATION ($42.31) |
| 2022 | $26.11 | 1 | Takeda Pharmaceuticals U.S.A., Inc. ($26.11) |
| 2019 | $43.18 | 3 | GENZYME CORPORATION ($43.18) |
| 2018 | $14.98 | 1 | GENZYME CORPORATION ($14.98) |
| 2017 | $10,750 | 24 | GENZYME CORPORATION ($6,512) |
All Payment Transactions
30 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/12/2024 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $42.31 | General |
| 07/06/2022 | Takeda Pharmaceuticals U.S.A., Inc. | VPRIV (Biological) | Food and Beverage | In-kind items and services | $26.11 | General |
| Category: GENETIC DISEASE | ||||||
| 09/26/2019 | GENZYME CORPORATION | POMPE - DISEASE (Drug), GAUCHER-DISEASE, FABRY-DISEASE | Food and Beverage | In-kind items and services | $14.98 | General |
| 06/11/2019 | GENZYME CORPORATION | MPS I-DISEASE (Drug), GAUCHER-DISEASE, POMPE - DISEASE | Food and Beverage | In-kind items and services | $13.22 | General |
| 03/20/2019 | GENZYME CORPORATION | GAUCHER-DISEASE (Drug) | Food and Beverage | In-kind items and services | $14.98 | General |
| 08/07/2018 | GENZYME CORPORATION | XLSD (Drug) | Food and Beverage | In-kind items and services | $14.98 | General |
| 10/27/2017 | Shire North American Group Inc | — | Consulting Fee | Cash or cash equivalent | $3,003.00 | General |
| 10/27/2017 | Shire North American Group Inc | — | Travel and Lodging | In-kind items and services | $469.83 | General |
| 10/27/2017 | Shire North American Group Inc | — | Travel and Lodging | In-kind items and services | $158.63 | General |
| 10/27/2017 | Shire North American Group Inc | — | Food and Beverage | In-kind items and services | $50.00 | General |
| 10/27/2017 | Shire North American Group Inc | — | Food and Beverage | In-kind items and services | $30.00 | General |
| 10/27/2017 | Shire North American Group Inc | — | Food and Beverage | In-kind items and services | $25.00 | General |
| 10/27/2017 | Shire North American Group Inc | — | Food and Beverage | In-kind items and services | $21.60 | General |
| 10/27/2017 | Shire North American Group Inc | — | Food and Beverage | In-kind items and services | $20.25 | General |
| 10/26/2017 | Shire North American Group Inc | — | Travel and Lodging | In-kind items and services | $251.30 | General |
| 10/26/2017 | Shire North American Group Inc | — | Travel and Lodging | In-kind items and services | $143.23 | General |
| 10/12/2017 | Genzyme Corporation | GAUCHER-DISEASE (Drug), CERDELGA | Food and Beverage | In-kind items and services | $23.95 | General |
| 09/12/2017 | Alexion Pharmaceuticals, Inc. | Kanuma (Drug) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: Immunology | ||||||
| 09/07/2017 | PFIZER INC. | ELELYSO (Drug) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: METABOLIC DISEASE | ||||||
| 07/12/2017 | PFIZER INC. | ELELYSO (Drug) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: METABOLIC DISEASE | ||||||
| 06/22/2017 | GENZYME CORPORATION | NO PRODUCT DISCUSSED (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,382.00 | General |
| 06/22/2017 | GENZYME CORPORATION | NO PRODUCT DISCUSSED (Drug) | Travel and Lodging | In-kind items and services | $524.49 | General |
| 06/22/2017 | GENZYME CORPORATION | NO PRODUCT DISCUSSED (Drug) | Travel and Lodging | In-kind items and services | $193.80 | General |
| 06/22/2017 | GENZYME CORPORATION | NO PRODUCT DISCUSSED (Drug) | Food and Beverage | In-kind items and services | $141.83 | General |
| 06/22/2017 | GENZYME CORPORATION | NO PRODUCT DISCUSSED (Drug) | Food and Beverage | In-kind items and services | $69.25 | General |
About Debra-Lynn Day-Salvatore, M.D., PH.D
Debra-Lynn Day-Salvatore, M.D., PH.D is a Clinical Genetics (M.D.) healthcare provider based in New Brunswick, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1851403539.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Debra-Lynn Day-Salvatore, M.D., PH.D has received a total of $10,876 in payments from pharmaceutical and medical device companies, with $42.31 received in 2024. These payments were reported across 30 transactions from 5 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($5,382).
Practice Information
- Specialty Clinical Genetics (M.D.)
- Location New Brunswick, NJ
- Active Since 08/31/2006
- Last Updated 12/26/2019
- Taxonomy Code 207SG0201X
- Entity Type Individual
- NPI Number 1851403539
Products in Payments
- NO PRODUCT DISCUSSED (Drug) $6,488
- VPRIV (Biological) $40.35
- GAUCHER-DISEASE (Drug) $38.93
- ELELYSO (Drug) $31.54
- Kanuma (Drug) $19.50
- POMPE - DISEASE (Drug) $14.98
- XLSD (Drug) $14.98
- MPS I-DISEASE (Drug) $13.22
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.